International trade · 26/11/2013Updated: 10/17/2026 · 1 min read
GlaxoSmithKline to Establish Pharmaceutical Production Facility in North Carolina's Foreign-Trade Zone 93-Raleigh/Durham
Summary
GlaxoSmithKline, PLC, has submitted a notification to the U.S. Foreign-Trade Zone Board to establish a pharmaceutical production facility in North Carolina's Foreign-Trade Zone 93-Raleigh/Durham, located in Zebulon, North Carolina.
Original source language: Federal Register — Department of CommerceOpen original release →